The Lightweight Innovations for Tomorrow public-private partnership has drawn a five-year U.S. Dept. of War assignment to “disrupt manufacturing affordability” for ceramic ...
Hyderabad's public transport faces a major hurdle with poor last-mile connectivity, forcing commuters to rely on expensive ...
Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today ...
Anika Therapeutics, Inc. ( ANIK) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to Anika's Fourth Quarter and Year-End Earnings Conference Call.
Wave Life Sciences is rated Hold, reflecting high pipeline potential but significant clinical, regulatory, and commercial ...
Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026 Additional ...
PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 Earnings Call Transcript February 11, 2026 PolyPid Ltd. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.34. Operator: Greetings ...
Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, ...
Continued expansion of LYTENAVA (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026Additional European launches expected in 2026Type A meeting request submit ...
InvestorsHub on MSN
Spruce Biosciences reports positive FDA meetings as it prepares TA-ERT filing for rare pediatric disorder
Spruce Biosciences, Inc. (NASDAQ:SPRB) said it has completed two Type B meetings with the U.S. Food and Drug Administration (FDA), clearing key regulatory discussions ahead of its planned biologics ...
The Vice President of the US-based oil and energy giant, ExxonMobil, Dan Ammann, says his company’s investment in the development of gas offshore Guyana depends ...
Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results